Adeka (4401) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Aug, 2026Executive summary
Net sales increased 15.2% year-over-year to ¥117.0 billion in FY2026 Q1, with operating profit rising 42.7% to ¥15.6 billion and profit attributable to owners of parent up 47.8% to ¥10,710 million.
Overseas sales ratio grew to 55.9%, with overseas sales up ¥9.9 billion year-over-year.
Growth was driven by strong demand in chemicals, semiconductor materials, and environmental materials, while food products saw increased sales but decreased profit due to higher raw material costs.
The global economy remained uncertain due to resource price increases and Middle East tensions, but robust fiscal and monetary policies and AI-related capital investment supported business.
Financial highlights
Net sales rose from ¥101.6 billion in FY2025 Q1 to ¥117.0 billion in FY2026 Q1.
Operating profit increased from ¥10.9 billion to ¥15.6 billion year-over-year.
Ordinary profit increased 50.2% year-over-year to ¥16,620 million.
Comprehensive income nearly doubled to ¥20,357 million from ¥10,227 million a year earlier.
Gross profit margin improved, with gross profit at ¥35,429 million versus ¥28,950 million last year.
Outlook and guidance
Full-year net sales forecast revised to ¥462,000 million, up 10.9% year-over-year.
Operating profit forecast for the year is ¥50,000 million, up 20.1% year-over-year.
Profit attributable to owners of parent projected at ¥32,000 million, up 14.8% year-over-year.
Annual dividend forecast raised to ¥132.00 per share, including a commemorative dividend.
Latest events from Adeka
- Record-high profits and sales, led by life science and semiconductor growth, with further gains forecast.4401
Q4 20265 Jun 2026 - Profit rose on strong Life Science and Environmental Materials, offsetting Chemicals weakness.4401
Q3 202627 Apr 2026 - Profit and sales rose, led by Life Science, with stable outlook and higher dividend forecast.4401
Q1 202610 Mar 2026 - Life Science strength drove profit growth, offsetting Chemicals and Food Products weakness.4401
Q2 202610 Mar 2026 - Profits and sales grew, led by Chemicals and Food Products, with raised outlook and Life Science loss.4401
Q1 202510 Mar 2026 - Strategic investments and innovation in semiconductor materials target rapid global growth.4401
Investor presentation10 Mar 2026 - 3Q FY2024 saw higher sales and profits, driven by Chemicals and global expansion.4401
Q3 202510 Mar 2026 - Strong 1H FY2024 results and Chemicals growth led to higher guidance and dividend forecasts.4401
Q2 202510 Mar 2026 - Record sales and profit growth driven by Chemicals, with continued expansion and higher dividends forecast.4401
Q4 202510 Mar 2026